Answers are grounded in this paper and cite their sources.
mutations are strong disease accelerators in a RUNX1-RUNX1T1 AML mouse model, suggesting that H3K27me2/3 has an important and selective leukemia-suppressive activity in this genetic context.
No takes yet. Share an insight, caveat, or question.
Lehnertz et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: